This product is a research grade chemical and not a pharmaceutical product. While the same active enantiomer (R-(−)-apomorphine) is an approved medicine, it is not manufactured, packaged, or regulated as a clinical dosage form, so it should not be used in humans.
Fortfahren mit
A4393
R-(−)-Apomorphin -hydrochlorid Hemihydrat
calcined, ≥98% (with NaOH, titration)
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Größe/SKU | Verfügbarkeit | Preis |
|---|
Über diesen Artikel
Lineare Formel:
C17H17NO2 · HCl · 1/2H2O
CAS-Nummer:
Molekulargewicht:
312.79
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352210
EC Number:
206-243-0
MDL number:
Assay:
≥98% (with NaOH, titration)
Form:
calcined, (Powder to Crystalline Powder)
Storage condition:
protect from light, under inert gas
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenQuality Segment
assay
≥98% (with NaOH, titration)
form
calcined, (Powder to Crystalline Powder)
storage condition
protect from light, under inert gas
color
white to gray
mp
285-287 °C (lit.)
solubility
H2O: ~10 mg/mL, clear, yellow-green
SMILES string
Cl[H].Cl[H].[H]O[H].[H][C@]12Cc3ccc(O)c(O)c3-c4cccc(CCN1C)c24.[H][C@]56Cc7ccc(O)c(O)c7-c8cccc(CCN5C)c68
InChI
1S/2C17H17NO2.2ClH.H2O/c2*1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;;;/h2*2-6,13,19-20H,7-9H2,1H3;2*1H;1H2/t2*13-;;;/m11.../s1
InChI key
CXWQXGNFZLHLHQ-DPFCLETOSA-N
Gene Information
human ... DRD1(1812), DRD2(1813), DRD3(1814), DRD4(1815), DRD5(1816)
Application
Biochem/physiol Actions
R-(−)-Apomorphine acts as a non-selective D1 and D2 dopamine receptor agonist. It shows therapeutic effects against Parkinson′s disease and male erectile dysfunction. R-(−)-Apomorphine also shows neuroprotective, radical scavenging, and emetic effects. Apomorphine stimulates the brain chemoreceptor trigger zone. It stimulates the chemoreceptor trigger zone in the brain.
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description calcined, ≥98% (with NaOH, titration) | description European Pharmacopoeia (EP) Reference Standard | description ≥98% (HPLC), solid | description ≥98% (HPLC), solid |
| form calcined, (Powder to Crystalline Powder) | form - | form solid | form solid |
| assay ≥98% (with NaOH, titration) | assay - | assay ≥98% (HPLC) | assay ≥98% (HPLC) |
| Quality Level 200 | Quality Level - | Quality Level 100 | Quality Level 100 |
| solubility H2O: ~10 mg/mL, clear, yellow-green | solubility - | solubility DMSO: ~14 mg/mL, H2O: >5 mg/mL | solubility H2O: ≥5 mg/mL, DMSO: >20 mg/mL |
| storage condition under inert gas, protect from light | storage condition - | storage condition desiccated, under inert gas | storage condition under inert gas, desiccated |
| color white to gray | color - | color - | color white |
Signalwort
Danger
Gefahrencodes
Hazard Classifications
Acute Tox. 3 Oral
Lagerklasse
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
PSA (Persönliche Schutzausrüstung)
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Sicherheitshinweise
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
-
How many doses in the 100mg bottle?
1 answer-
Helpful?
-